Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein

British Journal of Haematology

Volumn 114, Issue 1, 2001, Pages 177-184

  Trambas, Christina ^a   Wang, Zemin ^a   Cianfriglia, Maurizio ^b   Woods, Greg ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Dye efflux; MDR1; Natural killer cells; P glycoprotein; Western blot analysis

Indexed keywords

DAUNORUBICIN; GLYCOPROTEIN P; PROTEIN ANTIBODY; RHODAMINE 123;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; CALCIUM CHANNEL BLOCKERS; CELL LINE; CELL MEMBRANE; CYTOPLASM; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; KILLER CELLS, NATURAL; MOLECULAR WEIGHT; P-GLYCOPROTEINS; VERAPAMIL; VINBLASTINE;

EID: 0034939981     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02885.x     Document Type: Article

References (35)

1. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
2. The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta cells is mediated by a 65-kDa mdr-like P-glycoprotein
3. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
4. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes
5. Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells
6. P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells
7. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells
8. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype
9. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833
10. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies
11. Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody
12. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP
13. Biochemistry of multidrug resistance mediated by the multidrug transporter
14. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: A role in cytotoxic effector function
15. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells
16. Fluorescent cellular indicators are extruded by the multidrug resistance protein
17. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells
18. P-glycoprotein expression and function in circulating blood cells from normal volunteers
19. Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs
20. Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MKK16 monoclonal antibody and AHC-52
21. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein
22. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)
23. In vitro translation of a 2.3-kb splicing variant of the hamster pgp1 gene whose presence in transfectants is associated with decreased drug resistance
24. Natural killer cell cytotoxicity and the multidrug resistance gene
25. Use of fluorescent dyes as molecular probes for the study of multidrug resistance
26. MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase
27. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase
28. Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833
29. Pharmacological insights from P-glycoprotein knockout mice
30. Disruption of the mouse MDR1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
31. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
32. Chloride and potassium conductances of mouse pancreatic zymogen granules are inversely regulated by an approximately 80-kDa MDR1a gene product
33. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: The FcR gamma III (CD16) molecule and NK cell differentiation
34. MDR1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood
35. Requirement of expression of P-glycoprotein on human natural killer leukemia cells for cell-mediated cytotoxicity